Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. FREYER G; LIGNEAU B; TRILLETLENOIR V
   COLONY-STIMULATING FACTORS IN THE PREVENTION OF SOLID TUMORS INDUCED BY CHEMOTHERAPY IN PATIENTS WITH FEBRILE NEUTROPENIA
   International journal of antimicrobial agents
   
   G. Freyer et al., "COLONY-STIMULATING FACTORS IN THE PREVENTION OF SOLID TUMORS INDUCED BY CHEMOTHERAPY IN PATIENTS WITH FEBRILE NEUTROPENIA", International journal of antimicrobial agents, 10(1), 1998, pp. 3-9
2. VINCENT P; GUASTALLA JP; PIEDBOIS P; WEBER B; GANEM G; CURE H; TRILLETLENOIR V; GOUPIL A; MIGNOT L; PUJADELAURAINE E
   TAXOL(R) (T) PLUS CARBOPLATIN (CB) IN PRETREATED OVARIAN-CANCER (OC) PATIENTS (PTS) - A RANDOMIZED COMPARISON OF 2 CARBOPLATIN DOSE CALCULATIONS (AUC VS BSA)
   Annals of oncology
   
   P. Vincent et al., "TAXOL(R) (T) PLUS CARBOPLATIN (CB) IN PRETREATED OVARIAN-CANCER (OC) PATIENTS (PTS) - A RANDOMIZED COMPARISON OF 2 CARBOPLATIN DOSE CALCULATIONS (AUC VS BSA)", Annals of oncology, 9, 1998, pp. 323-323
3. TRILLETLENOIR V; CUCHERAT M; GERARD JP; BOISSEL JP
   MAINTENANCE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER
   Lung cancer
   
   V. Trilletlenoir et al., "MAINTENANCE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER", Lung cancer, 21(3), 1998, pp. 221-223
4. BOMPAS E; FREYER G; TRILLETLENOIR V
   MANAGEMENT OF NON REMOVABLE NON-SMALL-CEL L LUNG-CARCINOMA - RECOMMENDATIONS FROM THE AMERICAN-SOCIETY-OF-CLINICAL-ONCOLOGY (ASCO)
   Bulletin du cancer
   
   E. Bompas et al., "MANAGEMENT OF NON REMOVABLE NON-SMALL-CEL L LUNG-CARCINOMA - RECOMMENDATIONS FROM THE AMERICAN-SOCIETY-OF-CLINICAL-ONCOLOGY (ASCO)", Bulletin du cancer, 85(2), 1998, pp. 125-127
5. GILLY FN; SAYAGBEAUJARD AC; BIENVENU J; AYMARD M; TOURAINEMOULIN F; FAVROT M; TRILLETLENOIR V; PAVIRANI A; COURTNEY M; FRANCOIS Y; GLEHEN O; BANSSILLON V; VIGNAL J; ROSS M
   GENE-THERAPY WITH ADV-IL2 (TG-1021) IN UNRESECTABLE DIGESTIVE ADENOCARCINOMA - PHASE I-II STUDY, FIRST INCLUSIONS
   Cancer gene therapy
   
   F.N. Gilly et al., "GENE-THERAPY WITH ADV-IL2 (TG-1021) IN UNRESECTABLE DIGESTIVE ADENOCARCINOMA - PHASE I-II STUDY, FIRST INCLUSIONS", Cancer gene therapy, 4(5), 1997, pp. 332-333
6. LIGNEAU B; FREYER G; GIRAUD S; ISAAC S; BOMBARON P; ESPINOUSE D; PLAUCHU H; FISCHER G; GERARD JP; LENOIR G; TRILLETLENOIR V
   NEUROSARCOMA IN A PATIENT WITH TYPE-1 NEU ROFIBROMATOSIS
   La Presse medicale
   
   B. Ligneau et al., "NEUROSARCOMA IN A PATIENT WITH TYPE-1 NEU ROFIBROMATOSIS", La Presse medicale, 26(10), 1997, pp. 458-463
7. FREYER G; LIGNEAU B; TRANCHAND B; ARDIET C; SERREDEBEAUVAIS F; TRILLETLENOIR V
   PHARMACOKINETIC STUDIES IN CANCER-CHEMOTHERAPY - USEFULNESS IN CLINICAL-PRACTICE
   Cancer treatment reviews
   
   G. Freyer et al., "PHARMACOKINETIC STUDIES IN CANCER-CHEMOTHERAPY - USEFULNESS IN CLINICAL-PRACTICE", Cancer treatment reviews, 23(3), 1997, pp. 153-169
8. TRILLETLENOIR V; FREYER G
   CLINICAL-PRACTICE GUIDELINES FOR THE USE OF TUMOR-MARKERS IN BREAST-CANCER AND COLORECTAL-CANCER - RECOMMENDATIONS OF THE AMERICAN-SOCIETY-OF-CLINICAL-ONCOLOGY (ASCO)
   Bulletin du cancer
   
   V. Trilletlenoir e G. Freyer, "CLINICAL-PRACTICE GUIDELINES FOR THE USE OF TUMOR-MARKERS IN BREAST-CANCER AND COLORECTAL-CANCER - RECOMMENDATIONS OF THE AMERICAN-SOCIETY-OF-CLINICAL-ONCOLOGY (ASCO)", Bulletin du cancer, 84(7), 1997, pp. 767-768
9. COTTO C; BERILLE J; SOUQUET PJ; RIOU R; CROISILE B; TURJMAN F; GIROUX B; BRUNE J; TRILLETLENOIR V
   A PHASE-II TRIAL OF FOTEMUSTINE AND CISPLATIN IN CENTRAL-NERVOUS-SYSTEM METASTASES FROM NON-SMALL-CELL LUNG-CANCER
   European journal of cancer
   
   C. Cotto et al., "A PHASE-II TRIAL OF FOTEMUSTINE AND CISPLATIN IN CENTRAL-NERVOUS-SYSTEM METASTASES FROM NON-SMALL-CELL LUNG-CANCER", European journal of cancer, 32A(1), 1996, pp. 69-71
10. FREYER G; DESCOS L; TRILLETLENOIR V; CHANG DH; GERARD JP
    ADJUVANT CHEMOTHERAPY IN CANCER OF THE CO LON
    La Presse medicale
    
    G. Freyer et al., "ADJUVANT CHEMOTHERAPY IN CANCER OF THE CO LON", La Presse medicale, 25(27), 1996, pp. 1241-1246
11. TRILLETLENOIR V; SOLER P; ARPIN D; BOHAS C; RIOU R; COURTFORTUNE I; ECOCHARD D; PEROL M; CORDIER JF
    THE LIMITS OF CHEMOTHERAPY DOSE INTENSIFICATION USING GRANULOCYTE-COLONY-STIMULATING FACTOR ALONE IN EXTENSIVE SMALL-CELL LUNG-CANCER
    Lung cancer
    
    V. Trilletlenoir et al., "THE LIMITS OF CHEMOTHERAPY DOSE INTENSIFICATION USING GRANULOCYTE-COLONY-STIMULATING FACTOR ALONE IN EXTENSIVE SMALL-CELL LUNG-CANCER", Lung cancer, 14(2-3), 1996, pp. 331-341
12. HULEWICZ G; GOLFIER F; CHATTE G; VITREY D; MARTEL I; RAUDRANT D; TRILLETLENOIR V
    PURE EMBRYONAL CARCINOMA OF THE OVARY - C ASE-REPORT AND REVIEW OF THE LITERATURE
    Bulletin du cancer
    
    G. Hulewicz et al., "PURE EMBRYONAL CARCINOMA OF THE OVARY - C ASE-REPORT AND REVIEW OF THE LITERATURE", Bulletin du cancer, 83(9), 1996, pp. 718-724
13. THIEBLEMONT C; FENDLER JP; TRILLETLENOIR V; PETRIS C; CHAUVIN F; BRUNATMENTIGNY M; DEVAUX Y; DEVONEC M; GERARD JP; PERRIN P
    PROGNOSTIC FACTORS FOR THE SURVIVAL IN IN FILTRATING BLADDER UROTHELIAL TUMOR - RETROSPECTIVE STUDY OF 158 PATIENTS TREATED BY RADICAL CYSTECTOMY
    Bulletin du cancer
    
    C. Thieblemont et al., "PROGNOSTIC FACTORS FOR THE SURVIVAL IN IN FILTRATING BLADDER UROTHELIAL TUMOR - RETROSPECTIVE STUDY OF 158 PATIENTS TREATED BY RADICAL CYSTECTOMY", Bulletin du cancer, 83(2), 1996, pp. 139-146
14. FALCHERO L; COIFFIER B; GUIBERT B; SOUQUET PJ; PINET SI; TRILLETLENOIR V
    MALIGNANT PLEURAL MESOTHELIOMA FOLLOWING RADIOTHERAPY FOR HODGKINS-DISEASE
    Bulletin du cancer
    
    L. Falchero et al., "MALIGNANT PLEURAL MESOTHELIOMA FOLLOWING RADIOTHERAPY FOR HODGKINS-DISEASE", Bulletin du cancer, 83(11), 1996, pp. 964-968
15. TRILLETLENOIR V; GREEN JA; MANEGOLD C; VONPAWEL J; GATZEMEIER U; LEBEAU B; DEPIERRE A; JOHNSON P; DECOSTER G; MATCHAM J; EWEN C
    RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR IN THE TREATMENT OFSMALL-CELL LUNG-CANCER - A LONG-TERM FOLLOW-UP
    European journal of cancer
    
    V. Trilletlenoir et al., "RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR IN THE TREATMENT OFSMALL-CELL LUNG-CANCER - A LONG-TERM FOLLOW-UP", European journal of cancer, 31A(12), 1995, pp. 2115-2116
16. NICOLAS JF; BERTHIER O; TRILLETLENOIR V; CLAUDY A; REVILLARD JP
    THE FUTURE OF MELANOMA STAGE-I - IMMUNOLO GY AND IMMUNOTHERAPY OF MELANOMA
    Annales de dermatologie et de venereologie
    
    J.F. Nicolas et al., "THE FUTURE OF MELANOMA STAGE-I - IMMUNOLO GY AND IMMUNOTHERAPY OF MELANOMA", Annales de dermatologie et de venereologie, 122(5), 1995, pp. 324-335
17. COTTO C; QUOIX E; THOMAS F; HENANE S; TRILLETLENOIR V
    PHASE-I STUDY OF THE SOMATOSTATIN ANALOG SOMATULINE IN REFRACTORY SMALL-CELL LUNG-CARCINOMA
    Annals of oncology
    
    C. Cotto et al., "PHASE-I STUDY OF THE SOMATOSTATIN ANALOG SOMATULINE IN REFRACTORY SMALL-CELL LUNG-CARCINOMA", Annals of oncology, 5(3), 1994, pp. 290-291
18. GERARD JP; TRILLETLENOIR V; THALABARD JC
    PRINCIPLES OF ADJUVANT TREATMENT IN GASTR OINTESTINAL-TRACT ONCOLOGY
    Gastroenterologie clinique et biologique
    
    J.P. Gerard et al., "PRINCIPLES OF ADJUVANT TREATMENT IN GASTR OINTESTINAL-TRACT ONCOLOGY", Gastroenterologie clinique et biologique, 18(8-9), 1994, pp. 710-713
19. WAGNER JP; MAHE MA; ROMESTAING P; ROCHER FP; BERGER C; TRILLETLENOIR V; GERARD JP
    RADIATION-THERAPY IN THE CONSERVATIVE TREATMENT OF CARCINOMA OF THE ANAL-CANAL
    International journal of radiation oncology, biology, physics
    
    J.P. Wagner et al., "RADIATION-THERAPY IN THE CONSERVATIVE TREATMENT OF CARCINOMA OF THE ANAL-CANAL", International journal of radiation oncology, biology, physics, 29(1), 1994, pp. 17-23
20. TRILLETLENOIR V; ARPIN D; MERCATELLO A; OSKHAM R; PALMER PA; SOUQUET PJ; CHAMPEL F; BOYER J; CORDIER JF; FRANKS CR; MOSKOVTCHENKO JF; BRUNE J; PHILIP T
    COMBINATION IL-2 AND CISPLATINUM - A PROMISING TREATMENT FOR BRONCHIOLOALVEOLAR CARCINOMA
    European journal of cancer
    
    V. Trilletlenoir et al., "COMBINATION IL-2 AND CISPLATINUM - A PROMISING TREATMENT FOR BRONCHIOLOALVEOLAR CARCINOMA", European journal of cancer, 29A(13), 1993, pp. 1917-1918
21. TRILLETLENOIR V; ARPIN D; BRUNE J
    OPTIMAL DELIVERY OF DOSE IN CANCER-CHEMOTHERAPY WITH THE SUPPORT OF HEMATOPOIETIC GROWTH-FACTORS
    European journal of cancer
    
    V. Trilletlenoir et al., "OPTIMAL DELIVERY OF DOSE IN CANCER-CHEMOTHERAPY WITH THE SUPPORT OF HEMATOPOIETIC GROWTH-FACTORS", European journal of cancer, 29A, 1993, pp. 14-16
22. CHAUVIN F; SOUQUET PJ; TRILLETLENOIR V; COURTFORTUNE I; PEROL M; ECOCHARD D; REBATTU P; LAENNEC E; BERNARD JP
    THE CLINICAL AND ECONOMIC-EVALUATION OF T HE INITIAL ASSESSMENT IN SMALL-CELL LUNG-CANCER
    Revue des maladies respiratoires
    
    F. Chauvin et al., "THE CLINICAL AND ECONOMIC-EVALUATION OF T HE INITIAL ASSESSMENT IN SMALL-CELL LUNG-CANCER", Revue des maladies respiratoires, 10(5), 1993, pp. 445-451
23. TRILLETLENOIR V; MORNEX F; CHAUVIN F; FOURNEL P; VOLOCH A; PEROL M; LAENNEC E; PIPERNO D; BOYER J; ARDIET JM; CARRIE C; MONTBARBON X; MARQUIS I; ROMESTAING P; MERE P; TALABARD JN; CHASSARD JL; GERARD JP; SCHMITT T; GUERIN JC
    LIMITED DISEASE SMALL-CELL LUNG-CANCER - ALTERNATING COMBINATION OF DOXORUBICIN, ETOPOSIDE, IFOSFAMIDE AND HYPERFRACTIONATED RADIOTHERAPY -FINAL RESULTS OF A MULTICENTRIC PILOT-STUDY FROM THE GROUPE-LYONNAIS-ONCOLOGIE-THORACIQUE (GLOT)
    Lung cancer
    
    V. Trilletlenoir et al., "LIMITED DISEASE SMALL-CELL LUNG-CANCER - ALTERNATING COMBINATION OF DOXORUBICIN, ETOPOSIDE, IFOSFAMIDE AND HYPERFRACTIONATED RADIOTHERAPY -FINAL RESULTS OF A MULTICENTRIC PILOT-STUDY FROM THE GROUPE-LYONNAIS-ONCOLOGIE-THORACIQUE (GLOT)", Lung cancer, 10(1-2), 1993, pp. 35-45
24. TRILLETLENOIR V; BRUNE J
    TREATMENT OF EPITHELIAL THYMOMAS
    Bulletin du cancer
    
    V. Trilletlenoir e J. Brune, "TREATMENT OF EPITHELIAL THYMOMAS", Bulletin du cancer, 80(12), 1993, pp. 1043-1050
25. ARPIN D; TRILLETLENOIR V; LASSET C; SOUQUET PJ; RIOU R; YOANIDIS I; GUIDOLLET J; CORDIER JF; BRUNE J
    INTEREST OF C-REACTIVE PROTEIN ASSAY IN S MALL-CELL LUNG-CANCER
    Bulletin du cancer
    
    D. Arpin et al., "INTEREST OF C-REACTIVE PROTEIN ASSAY IN S MALL-CELL LUNG-CANCER", Bulletin du cancer, 80(12), 1993, pp. 1063-1068
26. CHAUVIN F; TRILLETLENOIR V; CORDIER JF
    SEQUENTIAL STAGING SYSTEMS FOR SMALL-CELL LUNG-CANCER
    Archives of internal medicine
    
    F. Chauvin et al., "SEQUENTIAL STAGING SYSTEMS FOR SMALL-CELL LUNG-CANCER", Archives of internal medicine, 153(19), 1993, pp. 2281-2281